GESTIÓN EN SALUD PÚBLICA: Updates on possible mitigation strategies to reduce the risk of nitrosamine drug substance-related impurities in drug products | FDA

martes, 23 de noviembre de 2021

Updates on possible mitigation strategies to reduce the risk of nitrosamine drug substance-related impurities in drug products | FDA

Updates on possible mitigation strategies to reduce the risk of nitrosamine drug substance-related impurities in drug products | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)